|Podcasts|July 11, 2019
Episode 35: Communicating Your Narrative with Healthcare Marketing
Author(s)Lisa Henderson, Christen Harm
Robert Finkel, the CEO of The FreshBlood Group talks with Pharm Exec editors about the positives and negatives of pharma’s marketing needs, the details and evolution around founding The FreshBlood Group, and how emerging pharma and biotech companies can budget in successful marketing.
Advertisement
Robert Finkel, the CEO of The FreshBlood Group talks with Pharm Exec editors about the positives and negatives of pharma’s marketing needs, the details and evolution around founding The FreshBlood Group, and how emerging pharma and biotech companies can budget in successful marketing.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition
2
FDA Approves Moderna's mRNA-Based Flu Vaccine
3
Amazon Pharmacy Launches GLP-1 Delivery Service
4
Your Questions Answered: The Biggest Pharma Stories of the Week of August 3-7, 2026
5